Donor-Acceptor Azetines via Chiral Copper Catalysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing donor-acceptor azetines lack efficient and enantioselective routes, particularly for forming 3-azetidinones, which are crucial for nucleophile coupling and peptide synthesis, due to limitations in catalysts and reaction conditions.

Innovation Solution

A highly enantioselective [3+1]-cycloaddition of silyl-protected enoldiazoacetates with aza-ylides using chiral copper(I) catalysis, specifically with Cu(MeCN)4PF6 and modified sidearm bisoxazoline ligands, to produce donor-acceptor azetines that facilitate ring opening reactions with nucleophiles, allowing for the formation of chiral peptide products with high efficacy and enantiopurity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used for synthesizing donor-acceptor azetines, then the synthesis can be achieved, but the enantioselectivity and efficiency are insufficient

Engineering Contradiction:
ImproveenantioselectivityVSAvoidsynthesis efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the chemical parameters by introducing chiral copper(I) catalysts with specific ligands (bisoxazoline, phenanthroline, cyclam) to achieve high enantioselectivity (up to 98% ee) while maintaining high productivity through optimized reaction conditions and substrate scope

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite catalytic systems combining copper(I) metal centers with chiral organic ligands to create highly enantioselective catalysts that simultaneously achieve high enantioselectivity and reaction efficiency for donor-acceptor azetine synthesis

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If 3-azetidinones are synthesized for nucleophile coupling, then peptide synthesis capability is achieved, but the ring opening reaction efficiency is limited without proper activation

Engineering Contradiction:
Improvenucleophile coupling capabilityVSAvoidring opening reaction efficiency
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent introduces electron-withdrawing groups at specific positions of the 3-azetidinone ring to create local electronic activation that facilitates nucleophile coupling while maintaining overall molecular stability and enabling diverse nucleophile reactions

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent pre-activates the 3-azetidinone ring by incorporating electron-withdrawing groups during synthesis, which prepares the molecule for efficient nucleophile coupling reactions without requiring additional activation steps

Inventive Principle:
Principle #10Preliminary action

3Adaptability or versatility

If broad nucleophile scope is achieved, then versatility of the method is improved, but reaction selectivity and enantiopurity retention become challenging

Engineering Contradiction:
Improvenucleophile scopeVSAvoidenantiopurity retention
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent develops a universal chiral copper(I) catalytic system that maintains high enantioselectivity across diverse nucleophiles including amines, alcohols, and other nucleophilic reagents, achieving both broad scope and high enantiopurity retention through the robust chiral catalyst design

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method provides a broad spectrum of peptide products with complete retention of enantiopurity and tolerates various nucleophiles, including amines, alcohols, and amino acids, offering a new methodology for attaching chiral peptide units and synthesizing amino acid derivatives with high yields and selectivity.

Implementation Method 1

A highly enantioselective [3+1]-cycloaddition of silyl-protected enoldiazoacetates with aza-ylides using chiral copper(I) catalysis

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

the 2-azetidine cycloaddition products undergo generation of 3-azetidinones by reactions with nucleophiles that produce a broad spectrum of peptide products by the retro-Claisen reaction

Methodology Applied
Scientific EffectRetro-Claisen reaction:

Data Source

PatentUS11377420B2Compositions and methods for making donor-acceptor azetines
Publication Date: 2022.07.05 BOARD OF RGT THE UNIV OF TEXAS SYST
  • US11377420B2 patent drawing
  • US11377420B2 patent drawing
  • US11377420B2 patent drawing

AI summary

A highly effective synthetic route to produce donor-acceptor azetines through the highly enantioselective [3+1]-cycloaddition of silyl-protected enoldiazoacetates with aza-ylides using chiral copper(I) catalysis is provided. In one embodiment, the 2-azetidine cycloaddition products undergo generation of 3-azetidinones by reactions with nucleophiles that produce a broad spectrum of peptide products by the retro-Claisen reaction provided by facile strain with high efficacy and complete retention of enantiopurity. This ring opening reaction uncovers a new methodology for the attachment of chiral peptide units to a variety of amines and alcohols, and tolerates a broad scope of nucleophiles including naturally occurring amines, alcohols, amino acids, and other nitrogen based nucleophiles.